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The effect of various non-intercalating minor groove binders on closed circular DNA in the presence of topoisomerase I has been studied by means 
of agarose gel electrophoresis. Analogues of the netropsin eries (lexitropsins) and SN-6999 can effectively produce positive supercoils, as indicated 
by analysis of the topoisomers in the presence of chloroquine and the evaluated linking number changes. Analogues of the distamycin series are 
less effective, and bisquaternary ammonium heterocycles, as well as DAPI and pentamidine, were found to be ineffective ligands. The large 
differences observed in the ability of minor groove binders to induce positive supercoils are discussed. 
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1. INTRODUCTION 
Variations in DNA supercoiling mediated by external 
ligands, such as proteins and small organic molecules, 
are of considerable interest as their effects could give 
information about the determinants of topological 
changes involved in transcription, replication, recombi- 
nation or DNA repair. Drug-induced effects on DNA 
play a role with respect o their interference with en- 
zymes of DNA metabolism, such as topoisomerases [1- 
3]. Binding of small intercalative ligands, such as EB or 
CQ, to a topoisomer unwinds DNA as a consequence 
of intercalation and, upon increasing ligand concentra- 
tion, alter the superhelix density from negatively super- 
coiled, via the relaxed, to the positive supercoiled state. 
Binding of the non-intercalative drug, Nt, to closed cir- 
cular DNA induces negative supercoiling. However, Nt 
is known to alter the superhelix density, producing pos- 
itive supercoils when it binds to DNA in the presence 
of topoisomerase I, and it is subsequently removed by 
phenol treatment [4]. Since minor groove binders may 
differ in their binding ability to DNA [5], it was of 
*Corresponding authors. Fax: (49) (3641) 331 325. 
Abbreviations: EB, ethidium bromide; CQ, chloroquine; Nt, netrop- 
sin; Nt-lmx, netropsin analogues (lexitropsins) containing two (x = 2) 
or three (x = 3) N-methylimidazole r sidues; bis-Nt-x (x = 5,6,8) bi- 
functional netropsins linked by x methylene residues; Dst-3, distamy- 
cin A; Dst-2, analogue of distamycin containing two N-methylpyrrole 
groups; Dst-lm2, distamycin containing two N-methylimidazole 
groups; DAPI, 4',6-diamino-phenylindole; SN-6999, SN-16841, SN- 
13282, SN-6131, SN-6132, SN-18071, bisquaternary ammonium 
heterocycles. 
interest o investigate whether non-intercalators of dif- 
ferent structure will induce the same effect with variable 
efficiency. Using gel electrophoretic analysis in a com- 
parative study we found that the potency of non-inter- 
calators to modulate supercoiling of DNA strongly 
depends on the ligand structure and their differential 
binding behaviour. 
2. MATERIALS AND METHODS 
2.1. Drugs 
EB, CQ and DAPI were from Serva (Heidelberg); pentamidine was 
a gift from D. Schweizer (Vienna); Hoechst 33258 and Dst-3 were 
purchased from Sigma. Nt was a purified product isolated from Strep- 
tomyces netropsis as described previously [6]. Analogues of Nt and 
distamycin, including imidazole-containing lexitropsins, as well as bis- 
netropsins (bis-Nt-x), were synthesized in the laboratory of J.W. 
Lown. Bisquaternary ammonium heterocycles (SN-6999 and related 
bisquat's) were gifts of B. Baguley (Auckland, New Zealand). Struc- 
tures of lexitropsins are given in [5,7,8], bis-Nt-x in [9], and bisquat's 
can be found in [5,10]. Chemical structures of representatives of differ- 
ent classes of non-intercalators used are presented in Fig. 1. 
2.2. DNA 
Plasmid DNAs were purified from E. coli strains harbouring the two 
derivatives of pUCI8:pUC18-1.5 and pUC18-3.4, the clones were 
gifts of D. Schweizer (Vienna) [11,12]. pBR322 DNA was isolated 
from E. coli according to standard procedures by density gradient 
centrifugation. 
2.3. Enzymes 
Topoisomerase I was isolated from chicken erythrocytes according 
to the method described by Trask and Muller [13]. 
2.4. Topoisomerase 1-mediated assay of drug-plasmid DNA complexes 
Supercoiled plasmid DNA was equilibrated with added ligands for 
10 min prior to topoisomerase assay, then 0.5/tg DNA was relaxed 
with 1 U topoisomerase I in 50 mM Tris-HC1 (pH 8.0), 100 mM NaC1, 
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Fig. 1. Chemical structures of some representative members of differ- 
ent classes of minor groove binders: netropsin (A), distamycin A (B), 
pentamidine (C), DAPI (E), SN-6999 (F) and SN-18071 (G). 
respectively [12]. Fig. 2 shows the results of the relaxa- 
tion assay of pUC18-3.4 in the presence of increasing 
amounts of Nt-lm 3 (panel A) and SN-6999 (panel B). At 
a total ratio r" = 0.05 to r' = 0.2 (drug per nucleotide) 
both drugs induce changes in the superhelical density of 
the DNA, as indicated by the faster migration of the 
topoisomers. To determine the sign of the drug-induced 
supercoiling of topoisomers, samples were electro- 
phoresed in gels containing CQ. CQ intercalates into 
DNA and will shift negatively supercoiled DNA up- 
wards on the gel under our experimental conditions, 
while positively supercoiled or relaxed DNA is shifted 
downwards [14]. Fig. 2 demonstrates that in the pres- 
ence of 1.5 #g/ml CQ, Nt-lm3 and SN-6999 produce 
downward shifts (CQ in panels A and B, lanes 7-10). 
Therefore both drugs have induced positively super- 
coiled topoisomers at r'--0.05 ligand per nucleotide. 
Some positively supercoiled topoisomers appear al- 
ready at r' = 0.025 as indicated in presence of CQ (Fig. 
2, lane 7). Nt was found to produce the same ffect in 
CQ 
and 1 mM EDTA (total reaction volume 20#1) at 37°C for 2 h. DNA 
was then extracted 3 times with phenol equilibrated with 50 mM 
Tris-HCl (pH 8.0). The aqueous phases were treated 5times with ether 
to remove phenol, then DNA was precipitated with ethanol and dis- 
solved in TE buffer (10 mM Tris-HC1, pH 7.4, 0.1 mM EDTA). 
Samples were electrophoresed in 1% agarose gels in 50 mM Tris- 
acetate (pH 8.0), 20 mM sodium acetate, 2 mM EDTA, 18 mM NaCl 
at 30 V/cm for 18 h. Staining of the DNA in EB (0.5 #g/ml), photo- 
graphy and scanning of negatives have been described previously [3]. 
Gels with CQ contained CQ at concentrations of 1.5 #g/ml or 3 #g/ml 
in both the gel and the lectrophoresis buffer. 
3. RESULTS AND DISCUSSION 
To investigate the effect of various minor groove 
binders on the torsional tension of closed circular du- 
plex DNA, two plasmid derivatives of pUC18, contain- 
ing two different inserts with a nucleotide length of 309 
(pUC18-3.4) and 313 (pUC18-1.5) have been used [11]. 
The inserts have an AT content of 54.1 and 42.1 mol%, 
CQ 
1 2 3 4 5 6 7 8 9 10 
Fig. 2. Effect of Nt-lm 3 (A) and SN-6999 (B) on pUC18-3.4 plasmid 
DNA in the topoisomerase I-mediated relaxation assay (see section 2). 
CQ means electrophoresis was performed in the presence of 1.5 #g/ml 
CQ. Lane 1, DNA alone; lanes 2 10, total ratio r' = 0.001, 0.0025, 
0.005, 0.0075, 0.01, 0.025, 0.05, 0.1 and 0.2, respectively. 
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pUC18-3.4 DNA (not shown), which is similar to that 
reported by Snounou and Malcolm for pAT153 DNA 
[4]. We also compared the effect of Nt and SN-6999 on 
pBR322 DNA, which basically was the same, but super- 
coiled topoisomers appeared already at lower levels of 
the drugs; r '= 0.02 (not shown). Surprisingly, bifunc- 
tional analogues in the Nt series, which all bind AT- 
specifically to DNA, did not induce positive supercoil- 
ing with comparable or higher efficiency, as observed 
for the monomers, Nt and Nt-lm3 (gel data not shown; 
cf. Table I). Thus linkage of two monomeric Nt units 
does not increase, and even lowers, the potency of these 
ligands to induce supercoiling in DNA. The result for 
two examples of the distamycin series is shown in Fig. 
3. It is evident hat both the AT-specific drug, Dst-3, 
and the analogue, Dst-lm2, which permits binding to 
GC pairs [15], only induce weak downward shifts, as 
can be seen at rather high concentrations, r" = 0.1 and 
r' = 0.3, respectively (panel A, lanes 5,6; panel B, lanes 
6,7). For Dst-3, inhibition of the enzyme occurs at 
r' = 0.5, and therefore negatively supercoiled DNA per- 
sists (panel A, lane 7). Our results how that the potency 
of non-intercalative minor groove binders to induce 
changes in DNA supercoiling differs significantly 
among various types of the ligands. Since most of these 
non-intercalators prefer AT base pair sequences of B- 
DNA [5], it was of interest to compare the induced effect 
of various drugs between the two plasmid derivatives of 
Table I 
Change in linking number, ALk, induced upon binding of minor 
groove binders to plasmid DNA of pUC18-3.4 and pUC18-1.5 
Ligand dLk 
r' = 0.05 r' = 0.2 
Nt +2 +4 
Nt-lm2 +2 +4 
Nt-lm3 +2 +5 
SN-6999 +2 +2 
bis-Nt-6 0 +2 a 
bis-Nt-8 0 +1 a 
bis-Nt-5 0 0 
Dst-3 0 +1 b 
Dst-2 0 + 1 b 
Dst-lm 2 0 + 1 b 
SN-16841 0 0 
SN- 13282 0 0 
SN-6131 0 0 
SN-6132 0 0 
pentamidine 0 0 
DAPI 0 -2 
Hoechst 33258 c 
Chromomycin A3 c 
SN-18071 c 
Positive 3Lk results after removal of drugs 
assay (see section 2). 
"At r' = 0.075 and r' = 0.1 
bAt r" = 0.3 
c Inhibition of topoisomerase I 
in the topoisomerase I 
CQ 
1 2 3 4 5 6 7 
C,Q 
1 2 3 4 5 6 7 
Fig. 3. Effect of Dst-3 (A) and Dst-lm 2 (B) on pUC18-3.4 plasmid 
DNA in the topoisomerase I-mediated relaxation assay. CQ means 
electrophoresis was performed in the presence of 3 pg/ml CQ. Lane 
1, DNA alone; lanes 2 7, r' = 0.02, 0.05, 0.075, 0.1, 0.3, 0.5, respec- 
tively. 
pUC18, the inserts of which differ in their AT content 
and AT clusters [12]. However, pUC18-3.4 DNA did 
not show significant differences compared with pUC18- 
1.5 DNA for various ligands (data not shown). Obvi- 
ously the AT sequence preference of non-intercalators 
is not a determining factor in the potency of the drugs 
to induce positive supercoiling in the topoisomerase I 
assay. This conclusion is also supported by the observed 
effect of Nt-lm3 (Fig. 2) which, in contrast o Nt, can 
accept GC pairs on interaction with DNA [7,8,15 18]. 
Moreover, the AT-specific ligands, DAPI and pen- 
tamidine (Fig. 1), are ineffective in producing positive 
supercoils in DNA. Pentamidine starts to induce posi- 
tively supercoiled topoisomers first at r '= 0.3, and a 
further increase to r' = 1.0 produces only a slight en- 
hancement of topoisomers (not shown), whereas no ef- 
fect appears at low ligand concentration (Table I). For 
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DAPI no effect is found up to r '=  0.1 (not shown), 
whereas at high ligand concentrations, r '=  0.2 to 
r' = 0.5 negatively supercoiled topoisomers occur (Fig. 
4, lanes 4-6); for comparison Nt causes trong positive 
supercoiling, as shown in lane 7. Inhibition of topo- 
isomerase I by DAPI can be excluded, since enhance- 
ment of the drug concentration did not change the re- 
sult. The DAPI-induced negative supercoils can be ex- 
plained by an intercalation which may occur only at the 
higher concentration levels, as found by Kubista et al. 
[19]. Obviously, non-intercalative binding of DAPI oc- 
curring at lower concentrations does not produce posi- 
tive supercoils. From the gel electrophoretic data, the 
change in linking number, ALk, induced by various 
non-intercalators, has been obtained, and which can be 
used as a measure of the ability of the ligands to produce 
positive supercoils in the topoisomerase assay. For su- 
percoiled plasmid DNA the linking number Lk = 
Lko + ALk, where Lk and Lko are the linking numbers 
of a supercoiled topoisomer and the relaxed form of the 
plasmid. The superhelical density (specific linking dif- 
ference) of a topoisomer is given by the equation 
= ALk/ALko [20]. Table I summarizes the linking 
number change induced by all types of minor groove 
binders investigated. An attempt was made to calculate 
the average helical twist of the DNA increase for differ- 
ent ligands in the bound state, which requires knowl- 
edge of the amount of bound ligand molecules. How- 
ever, by using literature data available for various li- 
gand-DNA complexes, a high uncertainty appeared in 
the results caused by a wide variation of binding con- 
stants of individual ligands due to different DNA's and 
a variety of methods used and applied under different 
conditions. Thus totally unrealistic data are obtained 
for a correlation to our ligand-pUC18-3.4 complex, so 
that we prefer to compare the ALk values at a given total 
ratio, r', ligand per nucleotide, which can be taken as 
a measure of the ability of various non-intercalators to 
induce supercoiling in DNA. As indicated in Table I the 
potency of minor groove binders to induce positive su- 
percoiling (+ALk) is the highest for Nt and its ana- 
logues, including SN-6999, and it decreases for bis-Nt- 
6, whereas distamycins only produce a weak effect. If 
should be mentioned that in the topoisomerase assay, 
positive supercoiling results from the Nt-induced 
changes after removal of Nt; on binding to closed circu- 
lar DNA, however, Nt induces negative supercoiles [21]. 
The bisquaternary ammonium heterocycles (SN com- 
pounds), pentamidine, as well as DAPI, are ineffective 
agents. In general, this differential behaviour of non- 
intercalators i  supported by recent findings of a varia- 
tion of ligand-induced winding angle changes derived 
from sedimentation velocity studies [21]. For example 
total changes in the average DNA winding angle pro- 
duced at concentrations of drug molecules added per 
DNA molecule have been found for Nt and bis-Nt-6 of 
7.4 ° and 5.4 °, respectively, whereas for the weakly ef- 
CQ 
1 2 3 4 5 6 7 
Fig. 4. Effect of DAPI on pUC18-3.4 plasmid DNA in the topoiso- 
merase I-mediated relaxation assay. CQ means electrophoresis was 
performed in the presence of 3/~g/ml CQ. Lane l, DNA alone; lanes 
2-6, r' = 0.1, 0.2, 0.3, 0.4, 0.5, respectively; lane 7, r' = 0.1 Nt. 
fective drug, bis-Nt-5, a distinctly lower value of 2.2 ° 
was calculated [21]. Some deviations found in this latter 
report, e.g. a lower efficiency of Nt-lm 3 and a higher 
efficiency of bis-Nt-6, may be related to the different 
methods used. For Hoechst 33258, chromomycin A3 
and SN-18071, we were unable to detect ALk since these 
ligands clearly inhibited topoisomerase I (Table I). 
From sedimentation analysis, however, Hoechst 33258 
was found to be weakly effective (with a winding angle 
change of 2.5 °) and SN-18071 ineffective in inducing 
changes in supercoiling [21]. 
The capability of some minor groove binders to in- 
duce supercoiling in DNA cannot be related simply to 
a single binding property of the ligand. Several factors 
have to be considered which can determine the highest 
local fit in the minor groove depending on the ligand 
structure, and this may be associated with geometrical 
distortions leading to changes in supercoiling. Besides 
the geometry and flexibility of the ligand, its capacity 
to form hydrogen bonds to bases within the minor 
groove, together with electrostatic interactions and van 
der Waals contacts, may determine the efficacy of the 
non-intercalator to induce positive supercoiling of 
DNA in the topoisomerase assay. Although most of the 
groove binders (Fig. 1, Table I) prefer AT sequences, 
individual differences in their DNA binding effects have 
been documented by various methods (for reviews see 
[5,22,23]). Studies on X-ray crystal analysis of a N~ 
dodecamer complex have revealed that Nt, upon bind- 
ing to a homologous AT center, bends the helix axis by 
about 8 ° backward from the binding site and causes a 
widening of the minor groove [22,24]. The isohelical 
alignment within the groove is facilitated by the flexibil- 
ity of the Nt molecule and by the formation of a maxi- 
mal number of hydrogen bonds (displacing the spine of 
hydration on AT sequences), by electrostatic attraction 
(due to the deepest molecular electrostatic potential in 
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the AT minor groove [23]), as well as by contacts with 
the wall of the groove [24]. These factors may determine 
local structural perturbations and will depend on the 
chemical nature of the ligand. In a closed circular plas- 
mid the linking number is defined as Lk = Wr + Tw, 
where Tw is the twist and Wr is the writhe [20,24]. Helix 
axis bending could occur in several AT-rich Nt-binding 
regions on the plasmid, leading to a change of writhe, 
and hence it would alter the helical twist, which in turn 
results in a change of the linking number. In our case 
the increase in the linking number (Table I) also reflects 
an increase in the helical twist. In contrast to Nt, DAPI 
causes a much lower bending of the helix axis, as deter- 
mined by X-ray crystal analysis [25]; the lower effect 
was ascribed to the shorter DAPI molecule which is 
unable to produce a strong leverage on the helix axis 
[25]. This might explain the absence of any effect of 
DAPI on inducing positive supercoils, while the weak 
unwinding effect observed in our results (Fig. 4, Table 
I) can be ascribed to an intercalation at GC sites at high 
concentrations of DAPI [19]. The Nt analogues, Nt-lm2 
and Nt-lm 3, are also dicationic ligands and could cause 
a similar effect o Nt, but they accept GC pairs [16-18] 
and can therefore act on mixed AT/GC sequences. Bis- 
Nt-6 is less effective at increasing the linking number 
(Table I). That the result differs to some extent from the 
data obtained from a recent sedimentation a alysis [21] 
may be due to the different experimental methods used. 
The differential effect on plasmid DNA of bis-Nt-6 and 
bis-Nt-8 on the one hand and of bis-Nt-5 on the other 
(Table I) can be ascribed to a bidentate binding mode 
of the first two ligands and a monodendate binding of 
the latter [26,27]. Evidently, the whole molecule of bis- 
Nt-5 is not properly located within the minor groove 
(base interaction becomes out of phase) and therefore 
it is less effective than the monomer Nt molecule. Bis- 
netropsins would require AT-rich sequences at proper 
distances for adaption of their monomeric units, which 
alternatively could explain their lower efficiency of in- 
ducing positive supercoiling. 
The very weak or almost no effect of distamycins on 
the production of positive supercoiling i  DNA (Fig. 3, 
Table I) could be related to their monocationic struc- 
ture, although this is not proven at present. However, 
it is interesting to note that in contrast o Nt, X-ray 
studies have indicated that no distamycin-induced 
bending of the helix axis occurred for its complexing 
with the central part -AAATTT- of a dodecamer [28]. 
The ineffectiveness of most of the SN ligands (Table 
I) can be understood in terms of the relative rigidity of 
these compounds [29], which disfavours an optimal 
isohelical alignment along the minor groove so that a 
deep penetration of the whole molecule cannot occur. 
As an exception SN-6999 permits a better fit within the 
groove and therefore it behaves like Nt (Fig. 2, Table 
I). A significantly different change observed in visco- 
metric titrations between SN-6999 [30] and SN-18071 
(Reinert, K.E., unpublished ata) supports this inter- 
pretation. Pentamidine, which is an ineffective ligand, 
too, can form two hydrogen bonds only as well as van 
der Waals contacts and induces a narrowing [31] instead 
of a widening of the minor groove. This binding mode 
probably implies that pentamidine cannot effectively 
replace the spine of hydration in the minor groove and 
consequently perturbs the helix to a much lower extent 
compared to the effect of Nt. 
The results imply that the ability of non-intercalating 
groove binders to produce supercoils in DNA strongly 
depends on structural features of the ligands. The super- 
coiling potency of these drugs may also influence their 
inhibitory effects on DNA topoisomerases and other 
enzymes of DNA metabolism. 
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